PHVS icon

Pharvaris (PHVS)

NASDAQ

$28.37

-$1.11 (

-3.75%

)

1D
5D
1M
6M
1Y
5Y
Market open

PHVS: $28.37 / ₿ 0.0004 BTC / 42536 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$29.48
$11.51 - $29.85
$1.84B
5.56
$27.93
$117,139.66
64.96M
$28.10 - $28.47
$27.87 - $28.60
Yes

What is Pharvaris (PHVS)?

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

The Pharvaris (PHVS) stock price has been falling

The Pharvaris N.V. Ordinary Shares (PHVS) stock price today is $28.37, reflecting a -3.75% move since the market opened. The company’s market capitalization stands at $1.84B, with a daily trading volume of $117.14K shares. For investors tracking price trends, Pharvaris N.V. Ordinary Shares stock has ranged between $27.87 and $28.60 today. The previous closing price was $29.48.

Get started with Pharvaris (PHVS)

Ready to get started? Follow the steps below, or read our guide on how to buy Pharvaris stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy PHVS

Search for PHVS in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy PHVS.

PHVS FAQs

PHVS is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

PHVS is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Pharvaris N.V. Ordinary Shares (PHVS) has traded between a low of $11.51 and a high of $29.85.

PHVS is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Pharvaris? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
PHVS icon
PHVS

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Pharvaris in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

AIXI icon

AIXI

SKYQ icon

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

SDCCQ icon
YOTAR icon

YOTAR

LPCN icon

LPCN

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.